Hope Biosciences Research Foundation

This was a special access program for one 58-year-old man with severe nerve damage (polyneuropathy) caused by a rare condition called POEMS syndrome. The goal was to see if eight infusions of his own banked stem cells, given over 28 weeks, were safe and could help relieve his sym…

This was a special access program for a single two-year-old child with a severe, rare genetic muscle disease. Doctors gave the child 14 infusions of his own specially processed stem cells over nearly a year to see if it was safe and if it could help control the disease. The study…

This study tested whether a patient's own stem cells, collected from body fat, could help improve function after a chronic spinal cord injury. Three men with different types of spinal cord injuries received multiple infusions of their own cells over about a year. The main goals w…

This was a special access program for a single patient with ALS (Lou Gehrig's disease). The study tested whether infusions of the patient's own specially processed stem cells, given over 18 weeks, could help control the disease. Doctors closely monitored the patient's symptoms, p…

This expanded access program allowed up to 11 patients with early to moderate Parkinson's disease to receive their own banked stem cells intravenously. The trial aimed to evaluate whether these stem cells could help control Parkinson's symptoms and slow disease progression. Parti…

This program provided special access to an experimental treatment for one patient with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition where the immune system attacks the nerves. Doctors tested whether infusions of the patient's own previously stored stem ce…

This was a special access trial for one individual with severe cerebral palsy who had no other treatment options left. The goal was to see if infusions of the patient's own stem cells, collected from their body fat, could help control their condition. The patient received eight i…

This study aimed to test if infusions of donor stem cells (HB-adMSCs) could safely reduce joint pain and swelling in children with juvenile idiopathic arthritis. It planned to enroll 66 children aged 2-17 and compare the stem cell treatment against a placebo. The trial was withdr…

This expanded access program is testing whether stem cell injections can help control multiple system atrophy (MSA), a rare and progressive brain disorder. Up to 7 adults with confirmed MSA will receive monthly IV infusions and spinal injections of donor stem cells over 44 weeks.…

This was an individual patient request to test whether a person's own banked stem cells could safely help control Primary Lateral Sclerosis (PLS), a rare disease that affects nerve cells controlling movement. The single 83-year-old participant received multiple infusions of his c…

This is a special, single-patient treatment program for an 84-year-old man who had a stroke and hasn't improved with standard care. Doctors are testing whether six infusions of his own specially processed stem cells, given about a month apart, are safe and might help his recovery…

This study tested a personalized stem cell treatment for one patient with systemic lupus erythematosus (SLE), an autoimmune disease. The patient received stem cells that had been previously banked from their own body. Researchers aimed to see if this approach was safe and could h…

This study is testing whether multiple infusions of a patient's own stem cells, taken from their fat tissue, can help control multiple sclerosis. It is for up to 10 people with relapsing-remitting MS who were in a previous related study and did not receive the active treatment. T…

This study tested whether a patient's own previously stored stem cells could help people suffering from Long COVID. Adults with ongoing symptoms like severe fatigue, shortness of breath, or brain fog for over 12 weeks after COVID-19 received five intravenous infusions. The goal w…

This program tested the safety of using a patient's own stem cells to treat Parkinson's disease. It was for 10 older patients (ages 76-95) who had already banked their cells with the research sponsor. The main goal was to see if giving multiple IV infusions of these cells over 18…

This was a special access program for one individual with severe, untreatable pain in both knees from arthritis. The goal was to see if using the patient's own stem cells, given through an IV and injections directly into the knees, was safe and could reduce pain. The patient rece…

This program provided expanded access to an experimental stem cell treatment for adults with severe, long-term musculoskeletal pain. Participants received multiple intravenous infusions of a specific type of stem cell (HB-adMSCs) over about 32 weeks. The main goals were to check …